Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Arcellx, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 167 | 2 | 186 | +21 |
| Shares | 50.2M | 3.52M | 49.5M | +2.76M (+5.9%) |
| Value | $2.77B | $194.1M | $4.13B | +$1.56B (+60.3%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Arcellx, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (18)
Institutions that held Arcellx, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Man Group plc | 104,046 | $5.74M |
| Superstring Capital Management LP | 59,133 | $3.26M |
| Twinbeech Capital LP | 53,585 | $2.96M |
| Walleye Capital LLC | 41,144 | $2.27M |
| Algert Global LLC | 35,211 | $1.94M |
| Renaissance Technologies LLC | 27,072 | $1.49M |
| Schonfeld Strategic Advisors LLC | 23,148 | $1.28M |
| Connor, Clark & Lunn Investment Management Ltd. | 22,492 | $1.24M |
| Squarepoint Ops LLC | 15,829 | $873.6K |
| State of New Jersey Common Pension Fund D | 11,756 | $648.8K |
| Engineers Gate Manager LP | 11,228 | $619.7K |
| Winton Group Ltd | 8,761 | $483.5K |
| Corton Capital Inc. | 6,273 | $346.2K |
| Clough Capital Partners L P | 4,800 | $264.9K |
| Bridgefront Capital, LLC | 4,641 | $256.1K |
| National Bank of Canada | 1,500 | $80.4K |
| State of Wyoming | 1,250 | $69.0K |
| Pacer Advisors, Inc. | 488 | $26.9K |
Not filed for Q3 2024 yet (2)
Institutions that held Arcellx, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 3,516,364 | $194.1M |
| Institutional & Family Asset Management, LLC | 8 | $442 |